|
November 3, 2000
News this month
Testosterone therapy may benefit post-menopausal women
A dose of testosterone
may be a good thing for post-menopausal women undergoing hormone
replacement therapy. Estrogen mixed with methyltestosterone, also
known as androgen, improved sexual desire and response in women
who were dissatisfied with estrogen alone, according to a study
published in The Journal of Reproductive Medicine.
"Giving estrogen alone to menopausal women helped a little
bit, but gradually over time the effectiveness was lost," said
Philip Sarrel, MD, professor of obstetrics and gynecology at the
Yale School of Medicine, and principal investigator for the study.
"What we found in our study was the missing partthe lack
of androgen replacement."
The study enlisted volunteers dissatisfied with
hormone replacement therapy and experiencing hot flashes, vaginal
dryness, decreased libido, painful intercourse and fatigue.
Study conducted on mid-life women
For the purposes of this double-blind, randomized study, the investigators
enlisted 20 volunteers, ages 45 to 55 years, who were dissatisfied
with the effectiveness of hormone replacement therapy in relieving
menopausal symptoms. All women in the study were naturally or surgically
menopausal. They had taken estrogen replacement therapy for an average
duration of more than a year, but they were still experiencing menopausal
symptoms such as hot flashes, vaginal dryness, decreased libido, painful
intercourse and fatigue.
During this study, Dr. Sarrel gave half of the group conventional
estrogen replacement, and he added testosterone to the estrogen for
the other half. All of the subjects successfully completed eight weeks
of treatment. Investigators measured menopausal symptoms and quality
of life at regular intervals during the study using the Menopausal
Symptom Scale, which evaluates hot flashes, sleep disturbances, memory
changes, depression, anxiety and painful intercourse. Sexual function
was evaluated with a 10-question Sexual Activity and Libido Scale.
Investigators also drew regular blood samples to measure the levels
of various hormones and proteins in the subjects blood, including
estradiol, estrone, sex hormone binding globulin (SHBG) and beta-endorphin.
Women taking estrogen plus testosterone reported significant increases in sexual sensation and desire.
Testosterone benefited all subjects
The women taking estrogen plus testosterone reported significant increases
in sexual sensation and desire and more frequent intercourse after
four weeks and again at eight weeks after starting therapy. All the
estrogen-treated women except one reported "little" improvement
in sensation and desire. In the estrogen-androgen group, six out of
nine women described improvements as "quite a bit" or higher.
Other symptoms such as vaginal dryness or pain during intercourse,
hot flashes and disturbed sleep did not change significantly with
either treatment.
Levels of SHBG, a protein that binds most of a womans natural
testosterone, increased in the estrogen group and decreased in the
estrogen-androgen group. Lower levels of SHBG indicate higher levels
of free androgens in the bloodstream. The investigators concluded
that the beneficial effect of the estrogen-androgen combination on
sexual function could be attributed either to the androgen in the
medication or to the higher levels of free androgens in the bloodstream
of those women taking the estrogen-androgen therapy.
Many previous studies corroborate the role of androgens in enhancing
sexual desire in women and men. Studies have not, however, demonstrated
any significant improvement with estrogen therapy although this hormone
does play a beneficial role in relieving vaginal dryness and atrophy.
In this study, sexual function improved in the estrogen-androgen women
even though estrogen levels were lower than before the study, further
demonstrating estrogens do not play a significant role in influencing
sexual desire in women.
Physician Referral Online
A free and confidential service
of Yale-New Haven Hospital.
Physician Referral Online
Using your own criteria, you can request information from a database
of 900 area physicians who have registered to participate.
Request an appointment
We would be happy to assist you in scheduling an appointment with
a member of the hospital's medical staff. Use the link above or
call:
203-688-2000
or toll free
1-888-700-6543
to talk with a referral coordinator.
|

|

Role of androgens underplayed
Much of the focus
of treatment for post-menopausal symptoms has been on estrogen,
which is certainly an important and beneficial therapy for many
women; but in fact, women produce more testosterone than estrogens
daily, and their bodies convert the testosterone to estrogen. In
adult women, testosterone has long been known to play a key role
in sexuality, in the prevention of bone loss and increased bone
density. Like estrogen, testosterone production drops significantly
after menopause. Yet the impact of post-menopausal testosterone
decline has been far less studied than that of estrogen.
"In adult women, testosterone has long been known to play
a key role in sexuality, in the prevention of bone loss and increased
bone density."
In my practice, we have used this hormone successfully to treat not
only post-menopausal women but also women in their reproductive years
who have experienced a loss of interest in sex. Theres a straightforward
biochemical reason why some women who are on estrogen either for birth
control purposes or to treat menopausal symptoms might especially
need testosterone: Most of a woman's natural testosterone supply is
already "bound" to a protein called sex hormone binding
globulin or SHBG. Only about one percent of the bodys supply
is available to act on tissues.
Estrogen given alone triggers the production of more SHBG, which then
binds up more testosterone. The SHBG phenomenon explains the fatigue
and loss of libido that may accompany estrogen therapy, so a woman
who was not lacking in testosterone before she started hormone replacement
therapy may become deficient during the course of therapy.
"Women who have experienced a decrease in sexual interest
and pleasure might want to talk with their physicians about the possibility
of taking androgen supplements."
Who should consider taking it?
Women who have experienced a decrease in sexual interest and pleasure
might want to talk with their physicians about the possibility of
taking androgen supplements. There is a blood test to measure the
presence of free testosterone in your body, and your physician will
be able to determine if you are deficient.
In the study published in the Journal of Reproductive Medicine,
our subjects were otherwise healthy post-menopausal women who rated
their prior interest in sex as moderate to high. There are some women
who report a lifelong low level of desire, and there may be many other
factors in addition to androgen deficiency that contribute to this
profile.
"
testosterone is a key factor in maintaining muscular
strength and appetite. Some women also report improved concentration
and restored feelings of well-being."
The benefits
Our subjects reported their experience to be like the turning off
of a switch in their bodies. Their loss of libido was distressing
to them and threatened their sense of well-being. After treatment
with an estrogen-androgen compound, these women without exception
reported "feeling like themselves" again. In addition to
improving sexual desire, testosterone is a key factor in maintaining
muscular strength and appetite. Some women also report improved concentration and restored feelings of well-being.
A word of caution
There are adverse effects if women receive an excess of androgens.
These include skin reactions such as an increase in oiliness and acne,
an increase in body and facial hair and voice changes. Its important
women be monitored by their physicians to ensure they are receiving
the appropriate dose.
Choices for supplementing testosterone
Testosterone is available in a number of forms. Estratest ®,
which contains both estrogen and testosterone, has been available
by prescription for decades and has a long history of clinical safety
and efficacy. There is currently a testosterone patch on the market
for men, and within a few years, we expect this will be available
for women as well. There are also gels and creams that contain testosterone,
but we are unsure of how much of the active ingredient in these creams
enters the bloodstream, so I have been hesitant to prescribe any of
these until we have the results of long-term studies.
Estratest is currently the standard treatment. I advise my patients
to take the medication for a minimum of six weeks before deciding
whether it is working effectively since it can take a while before
any effect is noticed.
Dr. Sarrel is an
attending obstetrician/gynecologist at Yale-New Haven Hospital and
a professor of obstetrics and gynecology at the Yale University School
of Medicine.
|